Cargando…
Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover
The Hippo pathway has been identified as a key barrier for tumorigenesis, acting through downregulation of YAP/TAZ activity. Elevated YAP/TAZ activity has been documented in many human cancers. Ubiquitylation has been shown to play a key role in regulating YAP/TAZ activity through downregulation of...
Autores principales: | Thanh Nguyen, Hung, Andrejeva, Diana, Gupta, Rajat, Choudhary, Chunaram, Hong, Xin, Eichhorn, Pieter J A, Loya, Anand C, Cohen, Stephen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849470/ https://www.ncbi.nlm.nih.gov/pubmed/27462448 http://dx.doi.org/10.1038/celldisc.2016.1 |
Ejemplares similares
-
USP21 regulates Hippo pathway activity by mediating MARK protein turnover
por: Nguyen, Hung Thanh, et al.
Publicado: (2017) -
DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins
por: Nguyen, Hung Thanh, et al.
Publicado: (2017) -
Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011) -
Angiomotins link F-actin architecture to Hippo pathway signaling
por: Mana-Capelli, Sebastian, et al.
Publicado: (2014) -
The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development
por: Hirate, Yoshikazu, et al.
Publicado: (2014)